Stockreport

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel the [Read more]